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ABSTRACT
The main controversy of colon-rectal laparoscopic sur-
gery comes from its use as a cancer treatment. Two
points deserve special attention: the incidence of port-
site tumor implantation and the possibility of performing
radical cancer surgery, such as total mesorectum exci-
sion.
Once these points are addressed, the laparoscopic
approach will be used routinely to treat rectal cancer. To
clarify these points, 32 patients with cancer of the lower
rectum participated in a special protocol that included
preoperative radiotherapy and laparoscopic total
mesorectum excision. All data were recorded. At the
same time, all data recorded from the experience of a
multicenter laparoscopic group (Brazilian Colorectal
Laparoscopic Surgeons – 130 patients with tumor of the
lower rectum) were analyzed and compared with the
data provided by our patients. Analysis of the results sug-
gests that a laparoscopic approach allows the same effec-
tive resection as that of conventional surgery and that
preoperative irradiation does not influence the incidence
of intraoperative complications. The extent of lymph
nodal excision is similar to that obtained with open sur-
gery, with an average of 12.3 lymph nodes dissected per
specimen. The rate of local recurrence was 3.12%. No
port site implantation of tumor was noted in this series
of patients with cancer of the lower rectum.
Key Words: Laparoscopy, Laparoscopic mesorectum
excision.
INTRODUCTION
Although some pessimism about the treatment of cancer
of the lower rectum still exists, the last two decades of the
20th century have provided some encouraging results
principally as to the decreased incidence of local recur-
rence and the improvement in long-term survival rates.1-13
First of all, it was recognized that peri-rectal fat (mesorec-
tum) is important as a site of neoplasmic involvement,
essentially of lymph node invasion, and that a wide lat-
eral margin resection is necessary to decrease cancer
recurrence. As a matter of fact, several reports1-3 empha-
size that the so-called technique of total mesorectum
excision certainly decreased the incidence of local recur-
rence.
At the same time, quite a number of reports5,6,8-13 demon-
strate that the use of preoperative radiotherapy not only
decreases the incidence of local recurrence but also actu-
ally increases the long-term survival rate. A large number
of studies make this assertion.12-23 The association of
both methods proved to increase effectiveness.3,11,12,17,22
In the last 10 years, the emergence of colorectal laparo-
scopic surgery in benign diseases has made evident the
benefits of this particular technique as to postoperative
recovery.14,16-18,20-22 However, a laparoscopic approach
to colorectal cancer has been the subject of controversy,
mainly due to the possibility of cancer implantation at
the port site.15 Nevertheless, numerous authors, particu-
larly those working at well-structured colorectal centers
with experience in cancer and laparoscopic surgery,
have shown that a laparoscopic approach could provide
the same oncological results as that of conventional sur-
gery.13,14,17,22 
Rectal or pelvic surgery by laparoscopic methods has
several advantages: (1) better anatomical recognition of
nerves, arteries, and fascia; (2) easy removal of the spec-
imen through the perineum; (3) less postoperative dis-
comfort; (4) early feeding; (5) better cosmesis; and (6) a
shorter hospitalization.
Nonetheless, laparoscopic removal of a rectal cancer
deserves some special considerations: (1) Is it possible to
perform a total mesorectum excision laparoscopically?
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(2) Does preoperative radiotherapy render the laparo-
scopic surgery more difficult and increase intra- and post-
operative complications?
Once these questions are answered, the use of a laparo-
scopic approach to treat cancer of the lower rectum will
provide benefits for the patient such as (1) a decrease in
the incidence of local recurrence due to the association
of preoperative radiotherapy and the total mesorectum
excision surgical technique; (2) improvement in long-
term survival rates, because of preoperative radiotherapy;
and (3) better postoperative recovery as a result of the
laparoscopic approach. 
To elucidate these points, all patients with cancer of the
lower rectum admitted to our department between 1993
and 1998 participated in the special protocol. At the same
time, all data recorded from the experience of a multi-
center laparoscopic group (Brazilian Laparoscopic
Colorectal Surgeons – National Consensus)22 were ana-
lyzed, which permitted a larger number of patients and a
wider spectrum of results to be included in the study.
METHODS
Only patients with adenocarcinoma of the lower rectum
(from the pectinate line to 4 cm above it) with tumors clas-
sified as T1, T2, and T3 were admitted to the study. A total
of 32 of our patients and 130 patients from the National
Consensus were included in this trial. No distinction was
made as to gender or race. Volume, size, and fixation of
the tumor were registered by means of digital examination
and proctoscopy. Biopsy was performed not only to con-
firm the diagnosis of adenocarcinoma but also to establish
the cellular differentiation of the tumor. Carcinoembryonal
antigen (CEA) dosage was measured before radiotherapy.
Colonoscopy, abdominal ultrasound, abdominal and
pelvic computerized tomography, and preoperative radio-
therapy were also performed. Reexamination and reevalu-
ation of patients was performed when the irradiation treat-




Of the 32 patients, 16 were males (50%), 16 were females
(50%), and 93.75% were white. Of the 32 tumors, 8 (25%)
were classified as T3, the great majority of them occupying
the posterior hemi-circumference of the rectum (6 patients
in 8); 23 (71.8%) tumors were classified as T2 and only 1
(3.2%) as T1. 
The cellular differentiation of the tumors, before radio-
therapy and surgery, was as follows: 4 (12.5%) tumors
were considered highly differentiated, 11 (34.4%) tumors
were classified as moderately differentiated, and 17
(53.1%) tumors were poorly differentiated.
Twenty-four (68.75%) patients had a CEA level greater
than 8 ng, 7 (21.8%) had CEA between 7 and 8 ng, 2
(6.25%) had CEA level between 6 and 7 ng, and only 1
(3.1%) had a CEA level considered normal.
No synchronous tumors were found, but 3 (9.4%) of them
had associated polyps. No liver metastasis was diagnosed.
The pelvic tomography confirmed the previous clinical
diagnosis of T3, T2, and T1 tumors. 
The total dosage of preoperative radiotherapy was 4,000
cGy, with a daily dosage of 200 cGy, in the pelvic and per-
ineal fields (Linear Accelerator of 25 MEV). All patients
completed the irradiation therapy without major compli-
cations. Two (6.25%) had perineal dermatitis and one
(3.1%) had actinic cystitis.
The main purpose of the reevaluation was to determine
the effect of irradiation on the tumor. All tumors showed
a variable degree of involution: 31.25% of the patients had
a tumoral involution greater than 70% of the previous vol-
ume and area. Of these, 2 patients (6.25%) had an involu-
tion greater than 90%. Of the 8 tumors classified as T3
tumors before the radiotherapy, 4 of them were consid-
ered as T2 and 1 as T1 after irradiation. Of the 23 tumors
previously considered T2, 8 of them were considered as
T1; and all T2 tumors decreased in volume and area after
the irradiation (Figure 1). 
The average number of lymph nodes resected per speci-
men was 12.3, with a minimum of 8 and a maximum of
18. Positive lymph nodes (metastatic ones) were found in
34.3% of the patients.
Surgery was performed 10 to 18 days after the end of the
irradiation treatment depending on the patients’ condition.
The minimum time between the completion of irradiation
and surgical intervention was 10 days.
All intraoperative complications and conversions to con-
ventional surgery were recorded. No complications due to
the effects of radiotherapy (fibrosis or hemorrhage) wereobserved. Obesity and a narrow pelvis were the greatest
difficulties encountered in performing the total mesorec-
tum excision.
Conversion occurred in just 1 (3.1%) patient due to fixa-
tion of the tumor to the sacrum.
Each specimen was analyzed to confirm completion of a
total mesorectum excision. The lateral margin and the
integrity of the pelvic fascia and peri-rectal tissue were
evaluated at the same time that the distal margin was
measured. All 31 patients that had the rectum excised by
laparoscopy showed a complete removal of the mesorec-
tum (total mesorectum excision). Distal margin varied
from 0.5 cm to 3 cm. 
Cellular differentiation of the tumor was compared with
that obtained on initial biopsy. After irradiation was com-
pleted, evaluation of cellular differentiation showed that
the incidence of 12.5% of high-grade differentiation
recorded at initial diagnosis changed to 28.1% after the
completion of radiotherapy. The incidence of 34.4% of
moderate grade of differentiation observed at initial diag-
nosis changed to 53.1% after the completion of radio-
therapy. The incidence of 53.1% of low grade of cellular
differentiation observed at the initial diagnosis changed
to 18.8% after the completion of radiotherapy (Figure 2). 
Bowel function, feeding, ability to ambulate, and time of
hospitalization were recorded. Bowel function returned
in less than 24 hours in 90.6% of the patients. Every
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Figure 2. Evaluation of the cellular differentiation of the tumor,
comparing the results obtained before the irradiation and after
completion of the radiotherapy (the specimen excised by sur-
gery).
patient was fed during the first 36 hours. Even the older
patients began walking in the first 24 hours. Hospital stay
varied from 4 to 7 days, with an average of 5.12 days. All
patients were followed-up every 3 months for the first 2
years and every 4 to 6 months after 2 years; development
of recurrence was recorded, either local or widespread
recurrence. Local recurrence was observed in one
Figure 1. Tumoral evaluation before and after radiotherapy.
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(3.12%) patient 14 months after surgery. Two (6.3%)
patients showed diffuse disease (hepatic metastasis): both
with T3 tumors, poorly differentiated, that did not
decrease with irradiation were considered as T3N2M0 at
the initial surgery. No port site implantation was regis-
tered.
National Consensus 
Only 78 (60%) of the 130 patients underwent preopera-
tive irradiation, and the results showed involution on
tumor size and volume. However, a consensus about the
total tumor dose did not exist. No consensus existed
about the interval between the completion of irradiation
and surgery. The conversion rate to open surgery was
6.25%. Total mesorectum excision was accomplished in
all patients. The average number of lymph nodes per
specimen was 11.5. No port site implantation (metastasis)
was recorded.
DISCUSSION
The “revolution” of laparoscopic surgery after centuries of
conventional surgery gave rise to a series of discussions
and controversies. The main controversy, however, came
from the use of this method for the treatment of cancer.
Several points deserve special discussion: (1) the inci-
dence of port-site tumor implantation and (2) the possi-
bility of performing radical cancer surgery. 
As regards the concept of radical surgery, Heald’s1 com-
ments sound very appropriate: “Without an adequate
training and an adequate anatomic understanding the
total mesorectum excision is practically impossible.”
These words are more than adequate; in fact they are
fundamental for the practice of colorectal laparoscopic
surgery. Training of the surgeon, both in conventional
colorectal and laparoscopic surgery, is required to obtain
rational results. But when dealing with cancer, other
important and indispensable elements should be added:
oncological surgery requires preciseanatomic-pathologi-
cal knowledge and the ability to perform radical surgery.
The surgeon must be well trained and experienced.
Margins and extension of resection for malignancy are
different from those for benign disease and this implies
totally different training. Extensive knowledge of pelvic
and rectal anatomy is necessary to achieve good results
in conventional surgery for benign disease. This knowl-
edge is even more important for a laparoscopic
approach, especially rectal cancer. Although it is easier to
recognize anatomic structures with the optical view of
laparoscopy, it is more difficult to obtain a panoramic
view of the pelvis. At the same time, in laparoscopic sur-
gery, the surgeon looses a “hands-on” ability to recog-
nize structures and define limits.
So, considering the short period of time that has elapsed
since the beginning of laparoscopic surgery for colorec-
tal diseases, it is reasonable that the great majority of sur-
geons do not yet have enough experience to evaluate a
laparoscopic approach. This is the reason why this pro-
cedure should, initially, be done at special centers with
surgeons trained in colorectal, laparoscopic, and onco-
logical surgeries. Only in this way can results be expect-
ed to compare with those of conventional surgery. 
Perhaps a more controversial point is the use of preop-
erative radiotherapy for colorectal malignancy. Although
several reports have demonstrated that preoperative irra-
diation is effective in controlling local recurrence, no
consensus exists about the effectiveness of the treatment
on long-term survival rates. 
Two main issues were evaluated in our series: the capabil-
ity to excise the total mesorectum by laparoscopic means
and the incidence of complications due to preoperative
irradiation. Analysis of our results suggests that a laparo-
scopic approach allows the same effective resection as
conventional surgery and that preoperative irradiation does
not influence the incidence of intraoperative complica-
tions. Anatomic examination of the specimens excised by
laparoscopy led to the conclusion that a total mesorectum
excision (total peri-rectal excision) was achieved in all
patients. Preoperative radiotherapy did not create an intra-
operative hazard or change the surgical procedure. None
of the patients had an intraoperative rupture of the tumor
or overt spillage of carcinomatous cells. The extension of
lymph nodal excision was similar to that obtained by open
surgery, with an average of 12.3 lymph nodes dissected per
specimen, with positive lymph nodes in 34.4% of patients.
The rate of local recurrence observed after abdomino-per-
ineal excision of the rectum by the laparoscopic approach
with total mesorectum excision (total peri-rectal excision)
in patients previously irradiated was 3.12% (T3N2M0), sta-
tistically similar to that observed in conventional surgery.
No portal implant of tumors was reported in this series of
patients. But, study of the postoperative recovery showed:
the patient was able to move and eat precociously, bowel
habits returned early, and that patients were able to return
to their normal social activities sooner.References:
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